Mbuya, Kimberly Morland, Lynnette M. Neufeld, Vanessa Oddo, Cynthia Ogden, Colin Rehm, Scott Richardson, Sarah Ross-Viles, Marie Ruel, Julie Ruel-Bergeron, Garrison Spencer, Marie Spiker, Andrew Thorne-Lyman, Alison Tumilowicz, Kelsey Vercammen, Marissa Zwald

A completely new chapter presents the unique challenges of curriculum development for large, long, and integrated curricula.

New topics include diabetes and eating disorders, osteoporosis, involuntary feeding, innovative psychological strategies, and ethical dilemmas.

Packed with larger-than-life characters-from dedicated and ardent scientists to feuding Texas surgeons and brave patients-this book is a fascinating case study that speaks to questions of expectations, limitations, and uncertainty in a high-technology medical world.

At the heart of this issue, Elbe argues, lies something deeper: the rise of a new molecular vision of life that is reshaping the world we live in.

Analyzing the debates around how to understand and evaluate treatment efficacy, this book will appeal to anyone with an interest in LSD and psychedelics, as well as mental health professionals, regulators, and scholars of the history of psychiatry, psychotherapy, drug regulation, and pharmaceutical research and development.

It is of enormous value to the layperson, hungry for knowledge about how best to interact and help their loved one face the dreadful ravages of depression."-Nursing Times

"-from the foreword by Arthur L. Caplan, NYU School of Medicine